Europe’s off-patent industry has welcomed the European Parliament’s decision to approve by a significant majority a Regulation setting out a waiver that will allow firms to manufacture generics and biosimilars during the term of supplementary protection certificates (SPCs).
“The European Parliament today voted overwhelmingly with 572 members of parliament in favour to adopt the SPC manufacturing waiver,” celebrated...






